LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, November 8, 2016, prior to the conference call and live webcast at 8:00 a.m. ET, when the Company will discuss the results.
|
Conference Call Details
|
|
|
|
Date
|
Tuesday, November 8, 2016
|
|
Time
|
8:00 a.m. ET
|
|
Webcast
|
http://ir.valeant.com/events-and-presentations
|
|
Participant Event Dial-in
|
(877) 876-8393 (North America)
|
|
(973) 200-3961 (International)
|
|
Participant Passcode
|
49468113
|
|
Replay Dial-in
|
(855) 859-2056 (North America)
|
|
(404) 537-3406 (International)
|
|
Replay Passcode
|
49468113 (replay available until November 16, 2016)
|
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Elif McDonald
[email protected]
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
To view the original version on PR Newswire, visit:
http://www.prnewswire.com/news-releases/valeant-announces-third-quarter-financial-results-date-and-conference-call-details-300345912.html
SOURCE Valeant Pharmaceuticals International, Inc.
